Arqit Quantum: Paul Feenan converts grants to 1,036 shares
The three RSU award groups have quarterly vesting schedules, with one schedule extending through October 2028.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Arqit Quantum Inc. Chief Revenue Officer Paul Feenan reported converting 1,036 restricted share units into 1,036 ordinary shares on October 1, 2026. The RSUs convert one-for-one. The three award groups have quarterly vesting schedules: two extend through 2027, while one extends through October 2028.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Share Units F2 | 556 | $0.00 | $0.00 |
| Exercise | Restricted Share Units F3, F1 | 158 | -- | -- |
| Exercise | Restricted Share Units F4, F1 | 322 | -- | -- |
| Exercise | Ordinary Shares | 556 | $0.00 | $0.00 |
| Exercise | Ordinary Shares F1 | 158 | $0.00 | $0.00 |
| Exercise | Ordinary Shares F1 | 322 | $0.00 | $0.00 |
Footnotes (4)
- F1. The Restricted Share Units ("RSUs") convert into ARQQ ordinary shares on a one-for-one basis.
- F2. The RSUs vest quarterly in equal installments on October 1, 2026, and January 1, April 1, July 1, and October 1, 2027.
- F3. The RSUs vest quarterly in equal installments on October 1, 2026, and January 1, April 1, and July 1, 2027.
- F4. The RSUs vest quarterly in equal installments on October 1, 2026, and January 1, April 1, July 1, and October 1, 2027, and January 1, April 1, July 1, and October 1, 2028.
Key Figures
Key Terms
one-for-one basis financial
vest quarterly in equal installments financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.